
Description
Tirzepatide
Dual GIP/GLP-1 receptor agonist class peptide. Supply is limited to qualified institutions after destination-market review.
Technical identity, purity, packaging, and documentation are confirmed against the applicable product specification and batch COA before release.
Part of our peptide CDMO services range, supplied by a China peptide manufacturer with batch documentation.
| Attribute | Specification |
|---|---|
| Form | Lyophilized powder |
| Purity | Specified per order and verified by the applicable batch COA / analytical report |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813 Da |
| Sequence | Modified 39-residue GIP/GLP-1 receptor agonist peptide; includes a lipidated side chain |
| Solubility | Solubility is material-, concentration-, and buffer-dependent; use the applicable laboratory protocol and product specification |
| Storage | Store lyophilized material according to the product label and batch documentation; minimize repeated temperature cycling after preparation |
Supply is subject to buyer qualification and destination-market regulatory review. These products are not consumer offers and are not advertised to the public.



